-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Integrated Biopharma Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2024.
- Integrated Biopharma Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $12K, a 200% increase year-over-year.
- Integrated Biopharma Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $17K.
- Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2024 was $17K.
- Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2023 was -$20K, a 86.5% increase from 2022.
- Integrated Biopharma Inc annual Nonoperating Income (Expense) for 2022 was -$148K, a 110% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)